Amgen Names Phyllis Piano Vice President, Corporate Communications and Philanthropy
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Sept. 2, 2005--Amgen
(Nasdaq:AMGN) today announced the appointment of Phyllis Piano to the
position of vice president, Corporate Communications and Philanthropy.
Piano will be responsible for the company's strategic communications
platform, including internal and external communications, public
relations, communications issues management, master brand management,
web communications and Amgen's philanthropy efforts.
Piano joins Amgen after serving as vice president, Corporate
Affairs and Communications at Raytheon Company, a $20 billion
aerospace and defense company, and a member of Raytheon's leadership
team. Prior to joining Raytheon, she served as vice president, Public
Affairs for Cooper Industries, Inc., a manufacturer of electrical
products, tools and hardware, and automotive products. Piano also
spent 17 years at General Electric where she progressed through
positions of increasing responsibility in communications, including
her role as head of communications at GE Medical Systems.
Amgen discovers, develops and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science's promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a broad and deep pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
EDITOR'S NOTE: An electronic version of this news release may be
accessed via our Web site at www.amgen.com. Journalists and media
representatives may sign up to receive all news releases
electronically at time of announcement by filling out a short form in
the Media section of the Web site.
CONTACT: Amgen, Thousand Oaks
Mary Klem, 805-447-4587 (media)
Arvind Sood, 805-447-1060 (investors)